Today at stockmatusow, we focus on a Bio-Pharmaceutical company with several near-term catalysts and give our thesis why we believe the company makes for a good long term speculative investment. Synergy Pharmaceuticals (SGYP) focuses on the development of drugs to…
Free Articles
Catalyst Trade Alert *UPDATED With Chart* – Re-Bought Progenics (PGNX) – Price Target Opinion = $6.50
Disclosure: I bought 25k shares of $PGNX @ $5.45 Biorunup’s Mark sold to go on vacation. Sheff remains bullish. we do as well. This is a pure catalyst trade which I talk about in my latest video. If Adcom for…
UPDATED AND CORRECTED: PSivida: An Extremely Undervalued Ophthalmology Small Cap Investment With Upcoming Catalyst
pSivida (PSDV) has been on stockmatusow’s radar for over one year now, as we first wrote about the company in April of 2012 detailing the company’s good long term prospects. When it comes to small cap companies, the first thing we…
Our Final Solta Acquisition/Merger Thesis
Upon continual review and much thinking between myself and my team, here is what we believe will take place with Solta; New loan taken out by Solta to have the needed money for severance pay a bunch of people who…
Solta Medical Officially Hires An Investment Banker, Merger Or Acquisition Seems Close
In the on-going saga of Solta Medical (SLTM), the next chapter has been written, when on the company’s earning’s call yesterday, it announced it has hired Piper Jaffray as its financial advisor/investment banker to explore strategic alternatives. We have written…
Sunshine Heart’s Pulse System Could Revolutionize How Heart Failure Is Treated
Recent developments in the medical device industry have paved the way for some strong achievements in many different sectors of the health care industry. With regards to heart failure, significant developments date back to the first implantable pacemaker successfully inserted…
The Biotech Merger And Acquisition Buzz List
Merger and acquisition rumors are heard on a daily basis throughout the market. Some have merit and turn out to be true, while others turn out to be false and without merit. Today, I will cover some companies that I…
Important Upcoming Catalyst For Antares – FDA Decision Expected October 14
n a bit more deliberate than Jazz, but is coming along nicely. Antares started its royalty deals with a gel based platform, one being a royalty deal with Actavis, Inc. (NYSE: ACT) (formely Watson Pharma) for topical oxybutynin gel. Oxybutynin…
Bullish Free Articles Bullish Premium Articles Commentary Free Articles Commentary Premium Articles Free Articles Premium Articles
Edited: Is An Acquisition Of Solta Medical Imminent?
In my last article concerning Solta Medical Devices (SLTM), I remarked several times how I feel the company has good assets and the potential to grab significant market share in various segments. However, I do feel the company and its…
The Baker Brothers Increase Shares In Halozyme By 105%, Insider Makes Big Buy And Options Heat Up
Often times, certain biotech institutional investors just seem to pick winner after winner, and stay on a hot streak — so to speak. Baker Brothers LLC is one such institution that is becoming well-known and gaining great respect from the…
